Activating Compound | Comment | Organism | Structure |
---|---|---|---|
cocaine | cocaine treatment causes an increase in the ventral striatum in enzyme specific activity and enzyme relative mRNA amount determined by real time RT-PCR | Rattus norvegicus |
Cloned (Comment) | Organism |
---|---|
expression analysis by quantitative real-time PCR | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
N-[1-(R,S)-carboxy-3-phenylpropyl]-Ala-Aib-Tyr-4-aminobenzoate | specific TOP enzyme inhibitor JA-2 | Rattus norvegicus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
alpha-neoendorphin + H2O | Rattus norvegicus | - |
? | - |
? | |
alpha-neoendorphin + H2O | Rattus norvegicus Wistar | - |
? | - |
? | |
beta-neoendorphin + H2O | Rattus norvegicus | - |
? | - |
? | |
beta-neoendorphin + H2O | Rattus norvegicus Wistar | - |
? | - |
? | |
dynorphin 1-8 + H2O | Rattus norvegicus | - |
? | - |
? | |
dynorphin 1-8 + H2O | Rattus norvegicus Wistar | - |
? | - |
? | |
gondotropin-releasing hormone + H2O | Rattus norvegicus | - |
? | - |
? | |
gondotropin-releasing hormone + H2O | Rattus norvegicus Wistar | - |
? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | P24155 | - |
- |
Rattus norvegicus Wistar | P24155 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
brain | ventral striatum, hippocampus, and frontal cortex | Rattus norvegicus | - |
neuroendocrine cell | - |
Rattus norvegicus | - |
testis | - |
Rattus norvegicus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
(7-methoxycoumarin-4-acetyl)-Pro-Leu-Gly-Pro-dLys-(2,4-dinitrophenyl) + H2O | a fluorescent-quenched substrate | Rattus norvegicus | ? | - |
? | |
(7-methoxycoumarin-4-acetyl)-Pro-Leu-Gly-Pro-dLys-(2,4-dinitrophenyl) + H2O | a fluorescent-quenched substrate | Rattus norvegicus Wistar | ? | - |
? | |
alpha-neoendorphin + H2O | - |
Rattus norvegicus | ? | - |
? | |
alpha-neoendorphin + H2O | - |
Rattus norvegicus Wistar | ? | - |
? | |
beta-neoendorphin + H2O | - |
Rattus norvegicus | ? | - |
? | |
beta-neoendorphin + H2O | - |
Rattus norvegicus Wistar | ? | - |
? | |
dynorphin 1-8 + H2O | - |
Rattus norvegicus | ? | - |
? | |
dynorphin 1-8 + H2O | - |
Rattus norvegicus Wistar | ? | - |
? | |
gondotropin-releasing hormone + H2O | - |
Rattus norvegicus | ? | - |
? | |
gondotropin-releasing hormone + H2O | - |
Rattus norvegicus Wistar | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
TOP | - |
Rattus norvegicus |
Organism | Comment | Expression |
---|---|---|
Rattus norvegicus | cocaine treatment causes an increase in the ventral striatum in enzyme specific activity and enzyme relative mRNA amount determined by real time RT-PCR | up |
General Information | Comment | Organism |
---|---|---|
metabolism | enzyme activity changes in the brain might play important role in the balance of neuropeptide level correlated with cocaine effects | Rattus norvegicus |
physiological function | the enzyme is implicated in the processing of opioid peptides, including, beta-neoendorphin, alpha-neoendorphin, dynorphin 1-8 and nociceptin/orphanin, modifications on TOP activity can potentially result in alterations in the metabolism of these neuropeptides and in vivo could be related to cocaine addiction | Rattus norvegicus |